Skip to main content

Immunization Clinical Resources

The resources here supplement the BC Immunization Manual (Chapter 2: Immunization) in the BC Communicable Disease Control Manual.

Program updates & Q&As

These updates and Q&A documents support immunization service providers in British Columbia. The material is supplementary, and should be used as a complement to, the guidelines in the Communicable Disease Control Manual, Chapter 2: Immunization

The Q&A documents include the date of production. New information that reaches the public domain after the date of production is not incorporated. Practitioners must take responsibility for ensuring they have the most recent knowledge and are using the most recent guidelines relating to the situation with which they are dealing. 

Vaccine Status Reporting Regulation (VSRR)

Vaccine Status Reporting Regulation Information for Health Care Providers - Q&A (Jan 2020)

Part 3: Management of Anaphylaxis in a Non-Hospital Setting

At the direction of the B.C. Chief Nursing Officer Council a provincial decision support tool (DST) for the management of anaphylaxis, "Anaphylaxis: Initial Emergency Treatment by Nurses (Adult and Pediatric)" has been developed. The provincial DST was developed to ensure that the initial emergency management of anaphylaxis is consistent amongst all nurses across the province, in all settings. The provincial anaphylaxis DST is based upon the World Allergy Organization guidelines and has incorporated the most up-to-date evidence. The BC Immunization Manual, Part 3 - Management of Anaphylaxis in a Non-Hospital Setting has been revised to be consistent with the provincial DST.


Changes to the Rotavirus Immunization Program

Beginning May 2018 BC will begin transitioning to the use of pentavalent rotavirus vaccine (RV5, RotaTeq®) in the infant rotavirus immunization program. The main difference with this product change is the immunization schedule, as the schedule for RotaTeq® is 3 doses, rather than 2 doses of Rotarix®.  It is recommended that RotaTeq® be administered at 2, 4 and 6 months of age together with the other routine infant vaccines given at these ages.



Hepatitis A vaccine

HPV vaccines

INFANRIX vaccines

Influenza vaccines

MMRV vaccine

Meningococcal vaccine

Pneumococcal conjugate (PCV13) vaccine

Rotavirus vaccine

Varicella vaccine


Immunization schedules

Routine schedules

Children and adults may benefit from additional vaccines that are not included in the BC routine immunization schedules. For more information, see:

For complete guidelines, see the BC Immunization Manual, Part 1: Immunization Schedules 

Immunization record cards

MSP billing codes

Adverse events following immunization

For resources, see Adverse Events Following Immunization

For complete guidelines, see the BC Immunization Manual, Part 5: Adverse Events Following Immunization

Informed consent for immunization

For resources, see Informed Consent for Immunization

For complete guidelines, see the BC Immunization Manual, Appendix A: Informed Consent for Immunization 

Vaccine administration

Injection sites

Intranasal route (Flumist vaccine only)

For complete guidelines, see the BC Immunization Manual, Appendix B: Administration of Biological Products

Immunization forms & letters

Immunization communication

Immunizer education videos

SOURCE: Immunization Clinical Resources ( )
Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

Copyright © BC Centre for Disease Control. All Rights Reserved.

    Copyright © 2020 Provincial Health Services Authority.